Despite its limited size, this series of ten breast cancers demonstrates that regional heterogeneity in HER2 status is associated with further heterogeneity at the molecular level, and sometimes also at the protein level, since some tumour components presented with different hormone receptor status and/or EGFR protein expression status. Here, EGFR is linked to breast cancer.